Zoetis Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Zoetis Inc. (ZTS) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $2.00 million for the 9-month period ending 2013-09-29, per its 10-Q filed 2014-11-10.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2014-11-10
- Zoetis Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-09-29 was $0.00.
- Zoetis Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-06-30 was $2.00M.
- Zoetis Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-03-31 was $2.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 9 month |
|---|---|---|---|
| 2013-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.00M derived: sum of 2 quarters · filed 2014-11-10 | $2.00M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $2.00M 10-Q · filed 2013-08-14 | $2.00M 10-Q · filed 2014-08-12 | |
| 2013-03-31 | $2.00M 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |